trending Market Intelligence /marketintelligence/en/news-insights/trending/akg3tswxxw5ctvbjblzwyq2 content esgSubNav
In This List

Coherus BioSciences appoints former Anthem exec to board

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Coherus BioSciences appoints former Anthem exec to board

Coherus Biosciences Inc. appointed Samuel Nussbaum to its board of directors.

The appointee is the former vice president of clinical health policy and chief medical officer of Anthem Inc., having served in those roles from 2000 to 2016.

The Redwood City, Calif.-based company said Nussbaum's appointment will help with Coherus' efforts to introduce its biosimilar medicines in the market.